CDMO

AVID BIOSERVICES : Management's Discussion And Analysis Of Financial Condition And Results Of Operations (form 10-K) | MarketScreener

AVID BIOSERVICES, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | MarketScreener

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2020 After Market Close on June 30, 2020 | MarketScreener

M&T Bank Corp Buys 7,620 Shares of Avid Bioservices Inc (NASDAQ:CDMO)

An Intrinsic Calculation For Avid Bioservices, Inc. (NASDAQ:CDMO) Suggests It's 67% Undervalued

Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19